Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Endocrine Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Malignant Endocrine Neoplasm
Endocrine Carcinoma

Subtype

Endocrine Carcinoma

CI-CAN-00000838Explore in graph →

575 active trials16 approved drugs58 evidence items

NCIt: C215715

Overview
Statistics
Survival
Genomics13
Variants & evidence58
Drugs22
Trials1791
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

1,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 575
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +1.5%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (236)

StatusAll Active (any)Completed 577 Recruiting 364 Unknown 251 Terminated 198 Active Not Recruiting 186 Not Yet Recruiting 134 Withdrawn 46 Enrolling By Invitation 13 Approved For Marketing 7 Suspended 7 No Longer Available 4 Available 4

PhaseAll Early Phase 1 14 N/A 159 Phase 1 484 Phase 2 906 Phase 3 158 Phase 4 16

No study matches these filters